Digoxin pharmacokinetics and MDR1 genetic polymorphisms (Q57314091)

7

0 references

author name string

Céline Verstuyft

1

0 references

Mathias Schwab

2

0 references

Elke Schaeffeler

3

0 references

Reinhold Kerb

4

0 references

Ulrich Brinkmann

5

0 references

Patrice Jaillon

6

0 references

Laurent Becquemont

European Journal of Clinical Pharmacology

8

0 references

publication date

1 March 2003

0 references

language of work or name

English

0 references

published in

0 references

volume

58

0 references

issue

12

0 references

page(s)

809-812

0 references

cites work

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-003-0567-5

Effect of grapefruit juice on digoxin pharmacokinetics in humans

21 January 2018

1 reference

12 December 2020

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

1 reference

12 December 2020

Modulation by dietary salt of verapamil disposition in humans

1 reference

12 December 2020

MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects

1 reference

12 December 2020